DOI: https://doi.org/10.36347/sasjm.2025.v11i10.017

Pages: 1036-1038

Schizophrenia is a chronic psychiatric disorder affecting 1% of the global population, leading to impaired quality of life and a high risk of hospitalization. Adherence to pharmacological treatment remains a major challenge. This six-month prospective and comparative study, conducted at the Ar-Razi University Psychiatric Hospital in Salé, evaluated the impact of psychoeducation on therapeutic adherence among 100 outpatients diagnosed with schizophrenia. The intervention group participated in weekly sessions focused on understanding the illness, managing treatment, family support, and relapse prevention. Results showed that psychoeducation significantly improved treatment adherence (64% vs. 41%), reduced hospitalizations (32% vs. 68%), and enhanced patients’ quality of life and satisfaction compared to the control group. These findings confirm that psychoeducation is an effective and low-cost intervention that promotes patient and family involvement in schizophrenia care.